// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Cultural Values in the ESADA Database

Renata L. Riha - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Patient and partner reporting sleepiness in patients with obstructive sleep apnoea using the Epworth Sleepiness Scale

Kallirroi Lamprou - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Impact of COVID lockdown on mood and sleep quality: Questionnaire-based survey

Tarang Kulkarni - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Impact of the novel coronavirus (COVID-19) pandemic on sleep

Laura Perez-Carbonell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Obesity

N/A

Sleep disorders in healthcare workers(HCWs) working in the frontline during the first wave of the COVID-19 pandemic

Nikolaos Athanasiou - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

A single centre experience of delivering a fully remote diagnostic and treatment pathway in patients with obstructive sleep apnoea

Andras Bikov - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sleep apnoea

N/A

Delivering sleep services in the COVID-19 era

Ashwin Rajhan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sleep apnoea

N/A

Ambulatory Sleep Service During the COVID 19 Pandemic - A New Norm?

Ujaas Dawar - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Repeatability of the Delta 12s index to screen for paediatric obstructive sleep apnoea

Hannah Ferrin - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Plasma metabolomics identifies obstructive sleep apnoea hypopnoea syndrome (OSAHS)

Scott O’Rourke - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

Inositol

Prevalence of sleep disruption and sleep disorders in patients with Post-Polio Syndrome

Yunis Fazaldin - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Late onset Pompe Disease: A rare cause of respiratory failure

Rajini Sudhir - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Glycogen storage disease 2

Acarbose

A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer

Dimitrios Magouliotis - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT)

Manoj Marathe - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Smoking of healthcare workers(HCWs) working in reference hospitals during the first wave of the COVID-19 pandemic

Nikolaos Athanasiou - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Smoking cessation activity in respiratory outpatient clinics

Kher Ng - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acquired immunodeficiency syndrome

N/A

Smoking and BMI in COPD and non-COPD patients

Spencer Keene - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Electronic cigarette use and perceptions amongst UK medical students: a cross-sectional study

Luke Holdsworth - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Increased exposure to tobacco smoke for children during the COVID-19 era

Mira Osinibi - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Inpatient smoking cessation during COVID-19: a highly teachable moment

Frederick Frost - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Copyright © 2026. QuantiNova All rights reserved